ABSTRACTS/POSTERS PRESENTED AT SCIENTIFIC MEETINGS

ZRT scientists have presented our innovative research at many scientific conferences over the years. This is a list of the abstracts and posters that we have presented.

  • “Challenges of Blood Spot Heavy Metal Testing – Using Blood Spot Area to Correct for Abnormal Sample Spread when Sample Matrix is Unknown.” Zava TT. 71st American Association for Clinical Chemistry Annual Scientific Meeting, Anaheim, CA, August 4-8 2019. See the poster presented.

  • “Dried Urine Analysis of Gadolinium, Thallium, and Uranium by ICP-MS with an Emphasis on Inter-Assay Stability of Samples Kept at Room Temperature.” Zava TT. 71st American Association for Clinical Chemistry Annual Scientific Meeting, Anaheim, CA, August 4-8 2019. See the poster presented.

  • “Post-Menarchal Adolescent Girls Demonstrate Multi-Level Reproductive Axis Immaturity.” Sun BZ, Kangarloo T, Adams JM, Sluss PM, Welt CK, Chandler DW, Zava DT, McGrath JA, Umbach DM, Hall JE, Shaw ND.  ENDO 2018, the Annual Meeting of The Endocrine Society, Chicago, IL, March 17-19, 2018. Abstract published in Endocrine Reviews 2018;39(2) Suppl, SUN-277. See the poster presented. See abstract.

  • “Dried Urine and Blood Spot Analysis of Essential and Toxic Elements by ICP-DRC-MS with an Emphasis on Inter-Assay Stability of Samples Kept at Room Temperature.” Zava TT. 69th American Association for Clinical Chemistry Annual Scientific Meeting & Clinical Lab Expo, San Diego, CA, July 30-August 3 2017. Abstract A402. See the poster presented.

  • “Dried Urine Mercury Stability and Quantification using a Direct Mercury Analyzer.” Zava TT, Zava DT. 12th International Conference on Mercury as a Global Pollutant, Jeju, Korea, June 14-19, 2015.
    See the poster presented.
  • “Dried Urine Multi-Element Analysis to Aid in the Prevention and Treatment of Iodine Deficiency Disorders; Measurement of Iodine, Bromine, Selenium and Arsenic by ICP-MS, with and without Creatinine Correction.” Zava TT, Zava DT.  30th International Conference of the Society for Environmental Geochemistry and Health, Newcastle-upon-Tyne, UK, June 30 – July 4, 2014.
    See the poster presented.
  • "Determination of Iodine, Bromine, Selenium and Arsenic by ICP-DRC-MS using Urine Dried on Filter Paper." Zava TT, Zava DT. 83rd Annual Meeting of the American Thyroid Association. San Juan, Puerto Rico, October 16-20, 2013. See the poster presented. Abstract published in Thyroid 2013;23(1):A21.
    See the abstract book.
  • “Ferritin Assay using Novel Dried Instant Plasma Spot Technology.”  Kapur S, Kapur S, Groves M, Zava D.  American Association for Clinical Chemistry Annual Meeting, Los Angeles, CA, July 15-19, 2012.
    See the poster presented.
  • “Measurement of vitamin D levels utilizing laboratory and dietary recall information from the Tennessee Children’s Respiratory Initiative.”  Koestner N, Hartert TV, Newman MS, Gebretsadik TS, Liu Z, Carroll K, Minton PA, Woodward KB, Larkin EK. American Thoracic Society 2010 International Conference, New Orleans, LA,  May 14-19, 2010.  Am J Respir Crit Care Med 2010; 181:A1890. 
    Abstract can be viewed on the journal’s website.
  • “Cardiometabolic risk factors and testosterone levels in men: implications for testosterone supplementation.”  Kapur S, Groves M, Zava D, Kapur S. 8th Annual World Congress on Insulin Resistance, Los Angeles, CA, Nov. 4-6, 2010. Abstract published in Diabetes and Vascular Disease Research 2011;8(1):p.73. See the poster presented. See the abstract book.
  • “Postprandial insulin and triglyceride levels after different breakfast meal challenges – measurement in dried blood spots (DBS).”  Kapur S, Groves M, Zava D, Kapur S. 7th Annual World Congress on Insulin Resistance, Los Angeles, CA, Nov. 5-7, 2009. Abstract published in Diabetes and Vascular Disease Research 2010;7(1). See the poster presented.
  • "Dried blood spot measurement of insulin levels provides a convenient tool to study postprandial dysmetabolism: a novel protocol for cardiometabolic risk assessment." Kapur S, Kapur S, Groves M, Zava D. Preventive Cardiovascular Nurses Association 16th Annual Scientific Meeting, Chicago, IL, April 15-17, 2010. Abstract published in J Cardiovasc Nursing 2010; 25(5):360. See the abstract book.
  • "Cardiovascular risk screening using simple and convenient dried blood spot technology." Kapur S, Kapur S, Groves M. Preventive Cardiovascular Nurses Association 16th Annual Scientific Meeting, Chicago, IL, April 15-17, 2010. Abstract published in J Cardiovasc Nursing 2010; 25(5):369.
    See the abstract book. See the poster presented.
  • “Dried blood spot study shows improvement of cardiometabolic risk with higher testosterone levels in men.” Kapur S, Kapur S, Norris W, Groves M, Zava D. Diabetes Science and Technology Meeting, Bethesda, Maryland, Nov. 13-15, 2008.
  • “Sex steroid monitoring during pregnancy using a saliva test.” Vanston C, Watson NV, Zava DT. Nurse Practitioners in Women’s Health 11th Annual Premiere Women’s Health Conference, Seattle, October 15-18, 2008. See the poster presented.
  • “Safety of maternal testosterone therapy during breast feeding.” Glaser R, Newman M, Parsons M, Zava D. 13th International Congress on Hormonal Steroids and Cancer, Quebec City, Canada, September 27-30, 2008. See the poster presented.
  • “Body mass index and salivary estradiol.” Zava DT, Newman MS. North American Menopause Society 19th Annual Meeting, Orlando, September 24-27, 2008. See the poster presented.
  • “Dried blood spot screening for cardiometabolic risk markers shows benefit of exercise.” Kapur S, Kapur S, Groves M, Zava D. American Diabetes Association 68th Scientific Sessions, San Francisco, June 6-10, 2008; Abstract 1046-P. See the poster presented.
  • “Association between testosterone and cardiometabolic risk: a dried blood spot analysis study.” Zava D, Kapur S, Norris W, Kapur S. International Academy of Compounding Pharmacists, Washington DC, May 31-June 3, 2008. See the poster presented.
  • “Quantitative analysis of 25-hydroxyvitamins D2 and D3 in dried bloodspot by liquid chromatography/tandem mass spectrometry.” Newman MS, Zava DT, Brandon TR, Groves MN. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting, Honolulu, May 2-6, 2008. See the poster presented.
  • “A novel model of care to reduce inflammation and improve cardiometabolic measures in perimenopausal and postmenopausal women.” Stephenson K, Neuenschwander P, Kurdowska A, Olusola P, Van Hook A, Kapur S, Zava D. Arteriosclerosis, Thrombosis, and Vascular Biology Annual Conference, Atlanta, Georgia, April 16-18, 2008. Arteriosclerosis, Thrombosis, and Vascular Biology 2008;28(6): page e70, Abstract P199. Abstract can be viewed on the journal’s website. See the poster presented.
  • “Extraction prior to enzyme immunoassay gives reliable salivary estradiol monitoring during estrogen therapy.” Newman MS, Stanczyk FZ, Zava DT. Society for Gynecologic Investigation 55th Annual Scientific Meeting, San Diego, March 26-29, 2008. See the poster presented.
  • “Cardiometabolic health monitoring using dried blood spot.” Kapur S, Kapur S, Zava D. Journal of Diabetes Science and Technology and 7th Annual Diabetes Technology Meeting, San Francisco, October 25-26, 2007.
  • “Dried blood spot screening of cardiometabolic risks.” Kapur S, Kapur S, Zava D. American Academy of Clinical Cardiology Annual Meeting, San Diego, July 15-19, 2007.
  • “Filter paper-dried blood spot assay of hemoglobin A1c.” Kapur S, Kapur S, Zava D. American Diabetes Association 67th Scientific Sessions, Chicago, IL, June 22-26, 2007; Abstract 2287-PO.
  • “Metabolic syndrome wellness screening program using dried blood spot.” Kapur S, Meyer W, Kapur S, Zava D. American Diabetes Association 67th Scientific Sessions, Chicago, IL, June 22-26, 2007;
    Abstract 2289-PO.
  • “Gender differences in high-sensitivity C-reactive protein as determined by dried blood spot assay.” Kapur S, Kapur S, Zava D. The Endocrine Society’s 89th Annual Meeting, Toronto, June 2-5, 2007. 
    See the poster presented.
  • “Transdermal estradiol and progesterone improve mood indicators, quality of life, and biomarkers of cardiovascular disease in perimenopausal and postmenopausal women.” Stephenson K, Kurdowska A, Neuenschwander P, Loewenstein I, Olusola P, Pinson B, Stephenson D, Kinsey R, Stephenson J, Stephenson J, Kapur S, Zava D. Abstracts from the 47th Annual Conference on Cardiovascular Disease Epidemiology & Prevention, Orlando, Feb 28-Mar 3, 2007. Circulation 2007; 115(8): page e277, Abstract P260. Abstract can be viewed on the journal’s website. See the poster presented.
  • “Filter paper dried blood spot assay of insulin measurement.”  Zava D, Kapur S, Kashi ZM.  American Diabetes Association 66th Scientific Sessions, Washington DC, June 9-13 2006; Poster 600-P.
     See the poster presented.
  • “Gonadotropin and steroid hormone testing by conventional serum venipuncture and finger-stick dried blood spot.”  Zava D, Kapur S, Kashi ZM.  Endocrine Society Annual Meeting, Boston, MA, June 24-26 2006. See the poster presented.
  • “Topical progesterone cream does not increase thrombotic and inflammatory factors in postmenopausal women.” Stephenson K, Price C, Neuenschwander P, Kurdowska A, Pinson B, Stephenson D, Stephenson J, Zava D, Alfred D, Krupa A, Mahoney D, Bevan M. Abstracts of the American Society of Hematology 46th Annual Meeting, San Diego, December 4-7, 2004. Blood 2004; 104(11 part 2):414b-415b.